Title : Sitagliptin: a novel agent for the management of type 2 diabetes mellitus.

Pub. Date : 2008 Mar 15

PMID : 18319497






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SUMMARY: Sitagliptin is a dipeptidyl-peptidase IV (DPP4) inhibitor that increases insulin release and decreases glucagon levels by preventing the activation of incretin hormones--glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Glucagon dipeptidyl peptidase 4 Homo sapiens
2 SUMMARY: Sitagliptin is a dipeptidyl-peptidase IV (DPP4) inhibitor that increases insulin release and decreases glucagon levels by preventing the activation of incretin hormones--glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Glucagon dipeptidyl peptidase 4 Homo sapiens